MD2875G2 - Remedy for nasal congestion treatment - Google Patents
Remedy for nasal congestion treatment Download PDFInfo
- Publication number
- MD2875G2 MD2875G2 MDA20040104A MD20040104A MD2875G2 MD 2875 G2 MD2875 G2 MD 2875G2 MD A20040104 A MDA20040104 A MD A20040104A MD 20040104 A MD20040104 A MD 20040104A MD 2875 G2 MD2875 G2 MD 2875G2
- Authority
- MD
- Moldova
- Prior art keywords
- remedy
- oil
- nasal congestion
- treatment
- nipazol
- Prior art date
Links
- 206010028735 Nasal congestion Diseases 0.000 title abstract 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 abstract 2
- OIVSLWMZGJLGKG-UHFFFAOYSA-N ethylthiourea;hydrobromide Chemical compound Br.CCNC(S)=N OIVSLWMZGJLGKG-UHFFFAOYSA-N 0.000 abstract 2
- 239000010642 eucalyptus oil Substances 0.000 abstract 2
- 229940044949 eucalyptus oil Drugs 0.000 abstract 2
- 229940041616 menthol Drugs 0.000 abstract 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 abstract 2
- 239000003921 oil Substances 0.000 abstract 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 abstract 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000012153 distilled water Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to medicine, namely to the clinical pharmacology and is meant for treatment of inflammatory nasal congestions.Summary of the invention consists in that the remedy comprises ethyl isothiuronium bromide, menthol oil, eucalyptus oil, polyethylene glycol, nipagin, nipazol in the following amount of ingredients: ethyl isothiuronium bromide 1,00…1,20g, menthol oil 0,20…0,30 g, eucalyptus oil 0,20…0,30 g, polyethylene glycol-400 4,0…6,0 g, nipagin 0,01…0,03 g, nipazol 0,03…0,05 g, distilled water up to 100 ml.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20040104A MD2875G2 (en) | 2004-05-04 | 2004-05-04 | Remedy for nasal congestion treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20040104A MD2875G2 (en) | 2004-05-04 | 2004-05-04 | Remedy for nasal congestion treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD2875F1 MD2875F1 (en) | 2005-10-31 |
| MD2875G2 true MD2875G2 (en) | 2006-05-31 |
Family
ID=35229987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20040104A MD2875G2 (en) | 2004-05-04 | 2004-05-04 | Remedy for nasal congestion treatment |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD2875G2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3619G2 (en) * | 2007-11-06 | 2009-01-31 | Рафаэль Баркан | Nasal remedy possessing vasoconstrictive and anti-edematous action |
| MD4291C1 (en) * | 2013-12-27 | 2015-02-28 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Medicinal preparation for the treatment of otitis |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090186854A1 (en) * | 2006-03-23 | 2009-07-23 | Meditor Pharmaceuticals Ltd. | S-alkylisothiouronium derivatives for the treatment of inflammatory diseases |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD263C2 (en) * | 1995-03-01 | 1995-12-31 | Виктор ГИКАВЫЙ | "Isoturon" means with antihypotensive activity |
-
2004
- 2004-05-04 MD MDA20040104A patent/MD2875G2/en not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD263C2 (en) * | 1995-03-01 | 1995-12-31 | Виктор ГИКАВЫЙ | "Isoturon" means with antihypotensive activity |
Non-Patent Citations (1)
| Title |
|---|
| Stroescu Valentin. Bazele farmacologice ale practicii medicale. Editura medicală, Bucureşti, 1999, p. 357-358 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3619G2 (en) * | 2007-11-06 | 2009-01-31 | Рафаэль Баркан | Nasal remedy possessing vasoconstrictive and anti-edematous action |
| MD4291C1 (en) * | 2013-12-27 | 2015-02-28 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Medicinal preparation for the treatment of otitis |
Also Published As
| Publication number | Publication date |
|---|---|
| MD2875F1 (en) | 2005-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP42808A (en) | Use of flibanserin in the treatment of sexual disorders | |
| BRPI0410721A (en) | foamable pharmaceutical compositions and methods for treating a disorder | |
| UA86063C2 (en) | Liposomes useful for drug delivery | |
| EP2013016A4 (en) | NANOPARTICLES OF LIPOSOME AND OTHER FORMULATIONS OF FENRETINIDE USEFUL IN THERAPY AND FOR THE DELIVERY OF MEDICAMENT | |
| WO2005115406A3 (en) | 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents | |
| EP1968684A4 (en) | RELIEF OF NASAL CONGESTION AND OBSTRUCTION AND DRUG DELIVERY | |
| EA200900491A1 (en) | USE OF ESTRADIOL VALERAT OR 17B-ESTRADIOL IN COMBINATION WITH DIENOGEST FOR ORAL TREATMENT TO MAINTAIN AND / OR INCREASE SEXUAL TREATMENT IN THE SPECIAL WOMAN | |
| DE69901936D1 (en) | NASAL SOLUTIONS | |
| ES2171440T3 (en) | SOLID COMPOSITION MUCOADHESIVA, THERAPEUTICS OR HYGIENIC, FOR ADMINISTRATION BY APPLICATION ON THE MUCOSA ORAL OR NASAL. | |
| MX388825B (en) | USE AND DOSAGE OF THERAPEUTIC AGENTS FOR ENDOMETRIOSIS. | |
| TW200603787A (en) | Topical preparations containing ambroxol | |
| CY1110369T1 (en) | NEW COOPERATIVE COMBINATION THAT INCLUDES Roflumilast And Formoterol | |
| PT1414467E (en) | TOP TREATMENT OF MASTALGIA | |
| EA200701923A1 (en) | DRUG FORM FOR THE ORAL ADMINISTRATION OF VITAMIN | |
| MD2875G2 (en) | Remedy for nasal congestion treatment | |
| EP1957652A4 (en) | PRO-APOPTOTIC BACTERIA AND COMPOSITIONS FOR ADMINISTRATION AND EXPRESSION OF ANTIGENS | |
| FR2915993B1 (en) | NEW AGONIST LIGANDS OF PARS RECEPTORS, USE IN HUMAN MEDICINE AS WELL AS IN COSMETICS. | |
| MD3619G2 (en) | Nasal remedy possessing vasoconstrictive and anti-edematous action | |
| HRP20050580B1 (en) | THE SYNERGISTIC EFFECT OF ROFLUMILAST AND (R, R) -FORMOTEROL COMBINATION | |
| EA200801854A1 (en) | NEW COMPOSITIONS | |
| NO20060743L (en) | Nasal pharmaceutical composition of piribedil | |
| WO2008022242A3 (en) | Synthesis of propyl phenoxy ethers and use as delivery agents | |
| ATE444072T1 (en) | PREVENTION OF EPITHELIAL CELL CARCINOMA | |
| TH69073A (en) | A stable topical formulation containing ketoprofen. | |
| DE50311479D1 (en) | PHARMACEUTICAL COMPOSITION, CONTAINING OXCARBAZEPINE WITH CONTROLLED ACTIVE INGREDIENTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |